- Home
- CAST vs QSI Comparison
CAST vs QSI Comparison
Compare CAST & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CAST | QSI |
|---|---|---|
| Founded | 2011 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 162.3M | 165.6M |
| IPO Year | 2020 | 2020 |
Fundamental Metrics
Financial Performance| Metric | CAST | QSI |
|---|---|---|
| Price | $1.33 | $0.78 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $6.00 | $1.00 |
| AVG Volume (30 Days) | ★ 8.1M | 3.0M |
| Earning Date | 06-26-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 28.17 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $2,436,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $618.07 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.50 | $0.69 |
| 52 Week High | $12.20 | $3.10 |
Technical Indicators
Market Signals| Indicator | CAST | QSI |
|---|---|---|
| Relative Strength Index (RSI) | 43.28 | 51.02 |
| Support Level | $0.67 | $0.70 |
| Resistance Level | $1.99 | $1.05 |
| Average True Range (ATR) | 0.34 | 0.06 |
| MACD | 0.08 | 0.01 |
| Stochastic Oscillator | 32.05 | 45.25 |
Price Performance
Historical ComparisonAbout CAST FreeCast Inc. Class A Common Stock
FreeCast Inc is a streaming technology company that provides platform-as-a-service solutions for television and digital video distribution. Its platform infrastructure supports telecom operators, internet service providers, broadcasters, municipalities, utilities, brands, and device manufacturers in deploying and managing digital media and streaming services.
About QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.